What drugs does SOFIE make?

SOFIE has 3 FDA-approved drugs.

What therapeutic areas does SOFIE focus on?

SOFIE focuses primarily on Oncology and Gastroenterology.

← Back

Data updated: Mar 10, 2026

SOFIE

OncologyGastroenterology

Generics

SOFIE is a generic drug manufacturer focused on Oncology, Gastroenterology.

2012

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

AMMONIA N 13 2026-02-13

Manufacturing (CMC)

FLUDEOXYGLUCOSE F18 2025-03-11

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 67%

0 drugs Phase 3: 2 Phase 2: 2

Gastroenterology 33%

0 drugs Phase 3: 1 Phase 2: 1

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Oncology, Gastroenterology

Bristol-Myers Squibb big-pharma

Oncology, Gastroenterology

Takeda big-pharma

Oncology, Gastroenterology

Gilead Sciences biotech

Oncology, Gastroenterology

ASTELLAS specialty

Oncology, Gastroenterology

SOFIE

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (3)

Active (3)

Discontinued (0)

Company Info